Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. prepare

PREPARE SIGNED

Preventing Respiratory Events through Proactive Assessment of Respiratory Effort

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 PREPARE project word cloud

Explore the words cloud of the PREPARE project. It provides you a very rough idea of what is the project "PREPARE" about.

775m    vp    unplanned    globally    120    market    allyn    mindray    multinational    trl7    sustain    adoption    irish    rate    2019    marked    million    companies    grow    hospital    patients    intermediate    asian    investigations    20    mou    platform    annual    america    rc    liabilities    ce    population    sales    hospitals    60m    ge    business    rr    ward    respirasense    negotiations    breathing    gt    generation    21    stay    monitoring    differentiated    distributors    settings    capture    distributor    total    25    10    accurate    500    asia    undertaking    solutions    30    postoperative    artifact    premier    patient    70    opportunity    length    continuous    first    2020    reject    team    prospects    medical    welch    validated    continents    clinical    16    respiratory    care    400    intensive    compromise    intervention    incidence    pmd    memorandum    31bn    world    5    monitor    7    event    marketing    107    admissions    save    197    countries    mortality    4    optimisation   

Project "PREPARE" data sheet

The following table provides information about the project.

Coordinator		 PMD DEVICE SOLUTIONS LIMITED 

Organization address
address: BISHOPSTOWN HOUSE MODEL FARM ROAD
city: CORK
postcode: T12T922
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Ireland [IE]
 Project website http://www.pmd-solutions.com/
 Total cost 4˙265˙610 €
 EC max contribution 4˙265˙610 € (100%)
 Programme 1. H2020-EU.3.1. (SOCIETAL CHALLENGES - Health, demographic change and well-being)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-2-2015
 Funding Scheme SME-2
 Starting year 2016
 Duration (year-month-day) from 2016-04-01   to  2018-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PMD DEVICE SOLUTIONS LIMITED IE (CORK) coordinator 4˙265˙610.00

Map

 Project objective

The incidence rate of Respiratory Compromise (RC) in hospital settings is 7% in intermediate/general care ward patients (107 million patients) and 30% in step-down postoperative patients (197 Million patients), at an average cost of €16,500 per event. It will cost the EU €31Bn by 2019. PMD’s technology will lead to a 20% reduction in the average patient length of stay, a 10% reduction in unplanned intensive care admissions, and a 5% reduction in liabilities from patient mortality by enabling early intervention of Respiratory Compromise (RC). This will be achieved by enabling the continuous and accurate monitoring of general ward patients respiratory rate (70% of the total patient population). The business opportunity is PMD Solutions (PMD), with its unique respiratory monitoring platform technology and its premier TRL7 CE marked product RespiraSense - the world’s first continuous respiratory rate monitor that is highly differentiated due to its ability to reject non-breathing artifact. This proposal, through the undertaking of clinical investigations, product optimisation, new product development and sales and marketing, will enable PMD to capture 0.4% of the market and sustain a 400% annual growth rate by 2020. It will lead to the generation of >€60M with sales across 3 continents including Europe, America and Asia and to grow the team from 10 to 21 within 3 years. PMD currently has 1 agreement with an Irish distributor and 7 Memorandum of Understanding (MoU) with other distributors across Europe with a further 25 other prospects. PMD is also in negotiations with the VP of marketing at each of the top 2 US (Welch Allyn, GE Medical) and the top Asian (Mindray) multinational patient monitoring companies. Globally hospital’s will save €775M over the next 3 years through their adoption of continuous monitoring of respiratory rate (RR). The unique technology platform has been validated on over 120 patients across 5 clinical areas in 5 hospitals, across 5 countries.

 Deliverables

List of deliverables.
PR collateral Websites, patent fillings, videos etc. 2019-05-31 16:50:40

Take a look to the deliverables list in detail:  detailed list of PREPARE deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREPARE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREPARE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.;H2020-EU.2.3.1.)

PREPARE (2016)

Preventing Respiratory Events through Proactive Assessment of Respiratory Effort

Read More  

ADVANTAGE (2015)

ADvanced Validation of A Novel TB Active disease diagnostic to address Global unmet needs: a European consortium approach

Read More  

SIME-LMT (2015)

Development of a digital diagnostics rapid Lung Maturity Test (LMT) for premature infants, to assist neonatologists in the diagnosis of Respiratory Distress Syndrome at birth

Read More